Lol! No worries at all!

Delighted that in addition to my role supporting impact for @kcl.ac.uk Health Faculties, I will now be supporting allocation of our Research England Participatory Research Funding! Gald to be back working with engagement colleagues and getting back to co-production and inclusive involvement spaces.

Thanks @louca-mai.bsky.social for putting this together! It’s about quiet for now but hopefully we can grow this space and move away from the toxicity of ‘X’

While the UK HE sector has a love hate relationship with the REF, other see a very rich source of data, if not flawed. It is great to see groups making use of it to go further and unpick impact and dymystify it some what: osf.io/preprints/so...

Screen grab of a notification from Web of Science that a paper has been cited in another paper.

The feeling when the system notifies that you have been cited but it turns out it’s a self citation! 🤦‍♂️

Cochrane Complementary Medicine on LinkedIn: ⚠️ How do we know if a certain treatment really works? Much health… ⚠️ How do we know if a certain treatment really works? Much health information available online is unreliable, and it’s important for everyone to develop…

What about #RareDiseases? It can be difficult to recruit enough patients for a ‘large’ study because simply they are not available or can’t be reached due to funding restrictions? How to we move this #Research on if we are immediately suspicious of small studies???

www.linkedin.com/posts/cochra...

Dr Laura Dennison on LinkedIn: #digitalhealth How to design equitable digital health tools. A narrative review of design tactics, case studies and opportunities This paper, by Amy Bucher and colleagues…

Bringing #equity to #digitalhealth tools! Yes please! More of this👇www.linkedin.com/posts/dr-laura-dennison_...

The BALANCE Study Phase 2a Two-site Randomised Controlled Trial to Determine Safety of and Adherence With a New ‘Binocularly Balanced Viewing’ Treatment for Unilateral Amblyopia Compared With Standard Treatment in…

Our recent publications in @bmj.com Open for the BALANCE study (clinicaltrials.gov/study/NCT037...; morph.co.uk/the-balance-...) made use of GRIPP2 and included an honest account of where our #PPI plans didn't pan out. pubmed.ncbi.nlm.nih.gov/35613759/ and pubmed.ncbi.nlm.nih.gov/39079927/

Hypermasculinity & Heartbreak with Jordan Stephens Jameela welcomes musician, actor and new author Jordan Stephens (Rizzle Kicks) for an open examination of modern masculinity, intimacy, and hope after heartbrea

Really interesting episode of iweigh with Jameela Jamil and Jordan Stephens podcasts.apple.com/gb/podcast/i... on the dangers of #hypermasculinity and an important reminder that #masculinity isn't automatically toxic. Follow it up with @mscaitlinmoran.bsky.social What About Men amzn.eu/d/37asPe8

Reporting PPI in research publications is the exception and not the rule Kevin J Munro is Programme Director of NIHR's Research for Patient Benefit Programme (RfPB), Dr Jennie Hejdenberg is Assistant Director of RfPB. Dominique Capostagno is a Senior Programme Analyst at N...

Important blog post from @nihr.bsky.social on the continuing underreporting of #PPI in #research publications. Thanks to @bmj.com who asked us to expand on the PPI in our last publication! We must report the learnings when PPI works and when it doesn't! www.linkedin.com/pulse/report...